Maglangit, Keith Thaddeus B.
HRN: 27-76-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2025
CEFTRIAXONE 1G (VIAL)
09/08/2025
09/15/2025
IVTT
1g
Q12
Ruptured Appendicitis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines